The $6 Million Drug Claim

August 26, 2019

New treatments for rare diseases are changing the lives of patients, but the price can reach millions of dollars for a single person

Quick Read

‘Maisie’s Army’

August 20, 2019

How a grassroots group is mobilizing to help toddlers access a lifesaving drug

Quick Read

The FDA almost never tests products itself. But in May, JAMA published the results of a randomized trial, conducted by FDA researchers, to determine whether the chemicals in four commercially available sunscreens are absorbed through the skin into the bloodstream

Quick Read

Forced off their parents’ insurance and faced with high insulin prices, young adults dangerously ration, stockpile, and turn to the black market for the medication they need to stay alive

Quick Read

Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”

Quick Read

More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read

Setting US drug prices based on prices paid in other countries could also improve affordability for Medicare beneficiaries according to a new study by researchers at Johns Hopkins, including our Michael DiStefano

Quick Read